AI-generated summary
The authors report a prospective, single-center study of a 650-microsecond 1064-nm Nd:YAG laser in people with mild to severe facial acne vulgaris, given as five treatments. They report a median lesion count reduction of 83.72% by treatment 3, sustained at 86.67% at 90 days, with high satisfaction and no adverse events observed.
- Who or what was studied
- Human subjects of Fitzpatrick skin types I to VI with mild, moderate, or severe facial acne vulgaris
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract describes a single-center study and does not report a control group or the total number of subjects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jddonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Digital object identifier. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.